Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.

Biotechnology

Interius Biotherapeutics

Phil Johnson

Philip R. Johnson M.D.

The Research and Development team at Interius Biotherapeutics focuses on advancing innovative cell and gene therapy technologies by driving the development of cutting-edge delivery systems. This team collaborates across various disciplines to improve drug product formulation, enhance analytical methodologies, and optimize manufacturing processes, ensuring the successful transition of scientific discoveries from the lab to clinical application.

Research and Development

About

Team members

Other teams at Interius Biotherapeutics

Research and Development

Leadership Team